Home › Funds › LOWE BROCKENBROUGH & CO INC › JNJ
LOWE BROCKENBROUGH & CO INC position in JNJ
JOHNSON & JOHNSON · Health Care
LOWE BROCKENBROUGH & CO INC reported holding 46,669 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$12.4M, representing 0.53% of its reported portfolio and ranking #48 among its reported holdings. LOWE BROCKENBROUGH & CO INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How LOWE BROCKENBROUGH & CO INC's JNJ position evolved
LOWE BROCKENBROUGH & CO INC first disclosed a stake in JNJ in Q3 2023 at 100,683 shares (US$15.7M). Across 13 filings, LOWE BROCKENBROUGH & CO INC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 46,669 shares valued at US$12.4M — a reduction of -991 shares quarter over quarter.. Notable position changes include a 40% trim in Q2 2025 (shares rose 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 100.68K | $15.68M | New |
| Q4 2023 | 94.59K | $14.83M | Reduce |
| Q1 2024 | 99.12K | $15.68M | Add |
| Q2 2024 | 98.69K | $14.42M | Hold |
| Q3 2024 | 94.23K | $15.27M | Reduce |
| Q4 2024 | 87.94K | $12.72M | Reduce |
| Q1 2025 | 91.59K | $15.19M | Add |
| Q2 2025 | 55.39K | $8.46M | Reduce |
| Q3 2025 | 49.48K | $9.18M | Reduce |
| Q4 2025 | 49.50K | $10.24M | Hold |
| Q1 2026 | 47.94K | $11.72M | Reduce |
| Q2 2026 | 47.66K | $12.10M | Reduce |
| Q3 2026 | 46.67K | $12.36M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About JNJ and 13F data
JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding JNJ
- BlackRock Inc 212.10M sh · $53.87B · Q2 2026
- Vanguard Group 240.35M sh · $49.74B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 157.76M sh · $41.76B · Q3 2026
- STATE STREET CORP 133.97M sh · $35.47B · Q3 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 65.65M sh · $17.38B · Q3 2026
- Geode Capital Management 65.50M sh · $17.30B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 59.09M sh · $14.97B · Q2 2026
- Morgan Stanley 44.81M sh · $11.38B · Q2 2026
- STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 31.59M sh · $8.36B · Q3 2026
- Norges Bank Investment Management 31.83M sh · $8.08B · Q2 2026
- Northern Trust Corp 28.79M sh · $7.31B · Q2 2026
- Capital World Investors 26.32M sh · $6.97B · Q3 2026
More on LOWE BROCKENBROUGH & CO INC
FAQ
How long has LOWE BROCKENBROUGH & CO INC held JNJ?
LOWE BROCKENBROUGH & CO INC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is LOWE BROCKENBROUGH & CO INC's current position in JNJ?
As of Q3 2026, LOWE BROCKENBROUGH & CO INC holds 46.67K shares of JNJ (JOHNSON & JOHNSON), valued at $12.36M, representing 0.53% of its reported portfolio and ranking #48.
Has LOWE BROCKENBROUGH & CO INC been buying or selling JNJ?
In the latest 13F filing (Q3 2026), LOWE BROCKENBROUGH & CO INC reduced its position in JNJ.
Which other funds hold JNJ?
Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.